Delivery Order SPE2DB25D3020-SPE2DB25FWKCE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,088.91 to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100 mg capsules. This non-competitive, firm fixed price delivery order was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. As a child contract under a larger vehicle, this delivery order represents a...
- The Defense Logistics Agency awarded a $1,725.36 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for 36,000 unit capsules of Creon DR 100s, with an ultimate completion date of August 8, 2025. The contract was competitively awarded with no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100s capsules, valued at $36,394.49. This firm fixed-price delivery order, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a non-competitive award under the company's existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of 36,000 units of Creon DR 100s capsules, valued at $6,150.38. This competitively awarded, firm fixed-price delivery order is set to be completed by July 30, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal...
- The Defense Logistics Agency awarded a $35,129.07 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for 36,000 unit capsules of Creon, a pancreatic enzyme replacement therapy used to treat pancreatic insufficiency. This competitive award, which is not set-aside, represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,004.53 to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100 capsules, with an ultimate completion date of July 30, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, awarded competitively on July 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Creon DR is an enzyme replacement therapy used to treat...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Creon DR 24,000 unit capsules (100 count) with a ceiling value of $2,262.52 and an ultimate completion date of August 11, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Creon DR 36,000 unit capsules in quantities of 100 units. This non-set-aside, firm fixed-price delivery order has a ceiling value of $6,733.40 and is scheduled for ultimate completion by August 19, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Creon DR 36,000 unit capsules in units of 100, with a contract ceiling value of $2,335.13 and an ultimate completion date of July 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $4,470.48 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon DR 100s on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed price, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWKCEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $42,783.63 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of 36,000 units of Creon DR 100s capsules. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award, and is scheduled for completion by August 20, 2025. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the contractor to supply comprehensive pharmaceutical and medical products globally to support military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor headquartered in Pennsylvania that regularly supplies medications, vaccines, medical devices, and specialized healthcare commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Creon DR product, a pancreatic enzyme supplement used in medical management, represents typical pharmaceutical procurement through the DLA's medical supply chain. As the prime contractor on this delivery order, AmerisourceBergen Drug Corp demonstrates continued capability to fulfill federal medical procurement requirements through its extensive portfolio of pharmaceutical distribution contracts with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $42.8k | 8/19/25 |